Clinical trials: sponsored by Chipscreen Biosciences, Ltd.
Solid Tumors
Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
The purpose of this dose-escalation study is to assess the safety and tolerability of treatment with Chiauranib administered orally over a range of doses in patients with advanced solid tumors.
- Trial name
- NCT02122809
- Testing
- Chiauranib
- Where
- China
- Volunteers
- 18 people
- Sponsor
- Chipscreen Biosciences, Ltd.
Non-small-cell Lung Cancer
Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer
The purpose of this study is to evaluate the efficacy and safety of Chidamide combined with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.
- Trial name
- NCT01836679
- Testing
- Chidamide, Paclitaxel, Carboplatin
- Where
- 8 sites in China
- Volunteers
- 124 people
- Sponsor
- Chipscreen Biosciences, Ltd.